Literature DB >> 18973894

Strategies to reduce multiple pregnancies due to ovulation stimulation.

Richard Palmer Dickey1.   

Abstract

OBJECTIVE: To review factors associated with high-order multiple births (HOMB) due to ovulation induction (OI) and the efficacy of strategies to reduce their occurrence.
DESIGN: Retrospective analysis of published studies of OI with intrauterine insemination (IUI) where patient and cycle characteristics were fully documented. RESULT(S): High-order multiple pregnancies (HOMP) were positively related to use of high doses of gonadotropin, number of 7-10 mm preovulatory follicles, and E(2), and inversely related to age and number of treatment cycles. Strategies successful in reducing HOMP include: use of clomiphene (CC) before gonadotropins, minimal gonadotropin doses, cancellation for more than three follicles >10-15 mm, and aspiration of excess follicles. Depending on the strategy used, 5%-20% of cycles may be canceled but HOMP rates can be less than 2% and pregnancy rates can average 10%-20% per cycle. Pregnancy rates per patient need not be reduced if low doses are continued for 4-6 cycles. CONCLUSION(S): High-order multiple pregnancies due to OI can be reduced to 2% or less by less aggressive stimulation without reducing overall chances of pregnancy for most patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973894     DOI: 10.1016/j.fertnstert.2008.08.008

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Maternal age and low birth weight: a reinterpretation of their association under a demographic transition in southern Brazil.

Authors:  C Homrich da Silva; A R Hernandez; M Agranonik; M Z Goldani
Journal:  Matern Child Health J       Date:  2013-04

2.  Costs of infertility treatment: results from an 18-month prospective cohort study.

Authors:  Patricia Katz; Jonathan Showstack; James F Smith; Robert D Nachtigall; Susan G Millstein; Holly Wing; Michael L Eisenberg; Lauri A Pasch; Mary S Croughan; Nancy Adler
Journal:  Fertil Steril       Date:  2010-12-04       Impact factor: 7.329

3.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

4.  Rescue in vitro fertilization using a GnRH antagonist in hyper-responders from gonadotropin intrauterine insemination (IUI) cycles.

Authors:  Jacques Balayla; Louis Granger; Pierre St-Michel; Marc Villeneuve; Jean-Yves Fontaine; Pascal Desrosiers; Elias M Dahdouh
Journal:  J Assist Reprod Genet       Date:  2013-05-30       Impact factor: 3.412

5.  Outcomes after intrauterine insemination are independent of provider type.

Authors:  Randi H Goldman; Maria Batsis; Michele R Hacker; Irene Souter; John C Petrozza
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

6.  Multiple pregnancy after gonadotropin-intrauterine insemination: an unavoidable event?

Authors:  Shirley A Fong; Vidya Palta; Cheongeun Oh; Michael M Cho; Jacquelyn S Loughlin; Peter G McGovern
Journal:  ISRN Obstet Gynecol       Date:  2011-12-29

7.  Ovulation induction with minimal dose of follitropin alfa: a case series study.

Authors:  Isidoro Bruna-Catalán; Marco Menabrito
Journal:  Reprod Biol Endocrinol       Date:  2011-10-24       Impact factor: 5.211

8.  Optimizing the number of embryos to transfer on day 5: two should be the limit.

Authors:  Claudio Ruhlmann; Lucas Molina; Graciano Tessari; Felicitas Ruhlmann; Lautaro Tessari; Diego Gnocchi; Antonio Cattaneo; Marcela Irigoyen; Alejandro Gustavo Martínez
Journal:  JBRA Assist Reprod       Date:  2017-02-01

9.  Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis.

Authors:  Yiping Yu; Lanlan Fang; Ruizhe Zhang; Jingyan He; Yujing Xiong; Xiaoyi Guo; Qingyun Du; Yan Huang; Yingpu Sun
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.